NDC 71671-100

Twirla

Levonorgestrel/ethinyl Estradiol

Twirla is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Agile Therapeutics, Inc.. The primary component is Levonorgestrel; Ethinyl Estradiol.

• Product ID: 71671-100_267bb687-4a33-44b0-8c0e-30a54b384942
• NDC: 71671-100
• Product Type: Human Prescription Drug
• Proprietary Name: Twirla
• Generic Name: Levonorgestrel/ethinyl Estradiol
• Dosage Form: Patch
• Route of Administration: TRANSDERMAL
• Marketing Start Date: 2020-09-11
• Marketing Category: NDA / NDA
• Application Number: NDA204017
• Labeler Name: Agile Therapeutics, Inc.
• Substance Name: LEVONORGESTREL; ETHINYL ESTRADIOL
• Active Ingredient Strength: 3 mg/1; mg/1
• Pharm Classes: Inhibit Ovum Fertilization [PE],Progesterone Congeners [CS],Progesterone Congeners [CS],Progestin [EPC],Progestin-containing Intrauterine Device [EPC],Estrogen Receptor Agonists [MoA],Estrogen [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 71671-100-01

1 POUCH in 1 CARTON (71671-100-01) > 1 PATCH in 1 POUCH (71671-100-11)

• Marketing Start Date: 2020-09-11
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details